Theratechnologies Inc (NASDAQ:THTX)’s traded shares stood at 7.66 million during the latest session, with the company’s beta value hitting 0.72. At the last check today, the stock’s price was $1.91, to imply an increase of 43.61% or $0.58 in intraday trading. The THTX share’s 52-week high remains $2.18, putting it -14.14% down since that peak but still an impressive 43.46% since price per share fell to its 52-week low of $1.08. The company has a valuation of $46.22M, with an average of 0.53 million shares in intraday trading volume over the past 10 days and average of 1.07 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Theratechnologies Inc (THTX), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give THTX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Theratechnologies Inc (NASDAQ:THTX) trade information
After registering a 43.61% upside in the latest session, Theratechnologies Inc (THTX) has traded red over the past five days. The 5-day price performance for the stock is 29.05%, and 25.66% over 30 days. With these gigs, the year-to-date price performance is 5.52%. Short interest in Theratechnologies Inc (NASDAQ:THTX) saw shorts transact 41858.0 shares and set a 0.33 days time to cover.
Theratechnologies Inc (THTX) estimates and forecasts
The rating firms project that company’s revenue will shrink -4.71% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 23.92M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 32.36M.Earnings reports from the last fiscal year show that sales brought in 30.05M and 30.92M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -20.39% before jumping 4.65% in the following quarter.
THTX Dividends
Theratechnologies Inc has its next earnings report out on 2025-Apr-08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Theratechnologies Inc (NASDAQ:THTX)’s Major holders
Theratechnologies Inc insiders hold 1.15% of total outstanding shares, with institutional holders owning 50.11% of the shares at 50.69% float percentage. In total, 50.11% institutions holds shares in the company, led by MAI CAPITAL MANAGEMENT. As of 2024-06-30, the company held over 29242.0 shares (or 0.0636% of shares), all amounting to roughly $40939.0.
Going by data provided on Feb 28, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 25.68 shares. This is just over 0.06% of the total shares, with a market valuation of $55214.0
